FDA.reportPublic FDA data

amlodipine / valsartan Pill

RxCUI
1152290
RxNorm name
amlodipine / valsartan Pill
Term type
SCDG
Status
Active
Updated
2026-10-27 19:27:35

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102011
Active start
102011
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
amlodipine17767
valsartan69749

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRamLODIPine / valsartan Pill1NAMES
RxNorm Nameamlodipine / valsartan Pill1NAMES
TTYSCDG1ATTRIBUTES
RxCUI11522901CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC09DBAngiotensin II receptor blockers (ARBs) and calcium channel blockersATC1-4amlodipine / valsartan
ATCC09CAAngiotensin II receptor blockers (ARBs), plainATC1-4valsartan
ATCC08CADihydropyridine derivativesATC1-4amlodipine
FDASPLD004095DihydropyridinesCHEMhas_chemical_structureamlodipine
FDASPLN0000175561Angiotensin 2 Receptor BlockerEPChas_epcvalsartan
FDASPLN0000175566Calcium Channel BlockerEPChas_epcamlodipine
FDASPLN0000175421Dihydropyridine Calcium Channel BlockerEPChas_epcamlodipine
FDASPLN0000000070Angiotensin 2 Receptor AntagonistsMOAhas_moavalsartan
FDASPLN0000000069Calcium Channel AntagonistsMOAhas_moaamlodipine
FDASPLN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaamlodipine
MEDRTD017311AmlodipineCHEMhas_ingredientamlodipine
MEDRTD000068756ValsartanCHEMhas_ingredientvalsartan
MEDRTD000788Angina Pectoris, VariantDISEASEmay_treatamlodipine
MEDRTD003324Coronary Artery DiseaseDISEASEmay_treatamlodipine
MEDRTD003928Diabetic NephropathiesDISEASEmay_treatvalsartan
MEDRTD004342Drug HypersensitivityDISEASEci_withamlodipine
MEDRTD004342Drug HypersensitivityDISEASEci_withvalsartan
MEDRTD006333Heart FailureDISEASEmay_treatvalsartan
MEDRTD006929HyperaldosteronismDISEASEci_withvalsartan
MEDRTD006973HypertensionDISEASEmay_treatamlodipine
MEDRTD006973HypertensionDISEASEmay_treatvalsartan
MEDRTD007022HypotensionDISEASEci_withamlodipine
MEDRTD007022HypotensionDISEASEci_withvalsartan
MEDRTD011247PregnancyDISEASEci_withvalsartan
MEDRTD018487Ventricular Dysfunction, LeftDISEASEmay_treatvalsartan
MEDRTN0000000070Angiotensin 2 Receptor AntagonistsMOAhas_moavalsartan
MEDRTN0000020065L-Calcium Channel Receptor AntagonistsMOAhas_moaamlodipine
MEDRTN0000008375Coronary Arterial VasodilationPEhas_peamlodipine
MEDRTN0000178477Decreased Blood PressurePEci_peamlodipine
MEDRTN0000178477Decreased Blood PressurePEhas_pevalsartan
MEDRTN0000178477Decreased Blood PressurePEhas_peamlodipine
MEDRTN0000008669Decreased Intravascular VolumePEhas_pevalsartan
MEDRTN0000008731Decreased Mineralocorticoid SecretionPEhas_pevalsartan
MEDRTN0000008859Decreased Renal K+ ExcretionPEhas_pevalsartan
MEDRTN0000009553Increased Renal Na+ ExcretionPEhas_pevalsartan
MEDRTN0000009825Renal Arterial VasoconstrictionPEci_pevalsartan
MEDRTN0000009826Renal Arterial VasodilationPEhas_pevalsartan

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH10 MG / 160 MG
ATTRIBUTESAVAILABLE_STRENGTH10 MG / 320 MG
ATTRIBUTESAVAILABLE_STRENGTH5 MG / 160 MG
ATTRIBUTESAVAILABLE_STRENGTH5 MG / 320 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESTallman SynonymamLODIPine / valsartan Pill